Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

7 Mar 2012 12:28

Small caps round-up; Cyan, Victoria, Physiomics ...

Semiconductor company Cyan Holdings has reported that 16 firms have submitted proposals for the tender relating to the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading, and that five of these are based on the company's Cylec technology. TNEB is one of the largest electricity distributors

Read more
1 Mar 2012 10:30

Small caps round-up: K3, Densitron, Innovation...

Software firm K3 Business Technology Group has received a number of indicative proposals at levels materially higher than the current share price, which it will explore these under a formal sale process and is now consequently in an offer period. Shares in the firm leapt 21.75 percent to 187.50p.

Read more
13 Sep 2011 16:58

London close: Good gains as FTSE 100 rallies

Stocks rediscovered their earlier buoyancy to finish with strong gains as hopes of a resolution of the euro crisis attracted buyers. Today's big mover, Cairn Energy, fell sharply after reporting disappointing results from its drilling campaign offshore Greenland, with one well coming up dry and ano

Read more
13 Sep 2011 12:07

London midday: Eurozone worries resurface

This morning's bright start seems a distant memory now, with shares firmly in the red as worries over the Eurozone situation take centre stage again. Today's big mover, Cairn Energy is sharply lower after reporting disappointing results from its offshore drilling campaign offshore Greenland, with o

Read more
13 Sep 2011 09:22

Physiomics wins prostate cancer drug deal

Physiomics, which makes computer models that simulate biological cell behaviour, has agreed to collaborate over development of a prostate cancer drug. The agreement with ValiPharam Limited will see Physiomics help test how the drug "VAL201" performs in combating tumour growth. In essence Physionom

Read more
15 Aug 2011 12:21

London midday: FTSE 100 stable after calm start

Shares are holding onto their gains today amid much calmer trading than the volatility seen last week. In company news, international recruitment firm Michael Page is sharply lower. It made a flying start to 2011 but said profit growth in the banking sector has tailed off in the second half of the

Read more
15 Aug 2011 11:50

Cancer results boost Sareum

Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method of controlling a cancer cells' response to DNA damage. The candidate, when orally dosed, reduces cancer growth rates compared to treatment with the

Read more
6 Apr 2011 15:13

Physiomics issues shares at discount

Penny stock Physiomics fell sharply Wednesday, giving back some of last week's heavy gains, after announcing a share issue at a discount to the prevailing market price. The company has issued 120m shares at a price of 0.5p per share by way of a placing, to raise £0.6m to boost working capital. Fo

Read more
1 Apr 2011 16:11

Physiomics hits 52-week high on study outcome

The Oxford based systems biology company Physiomics said positive results have been generated in a pre-clinical study into breast cancer based on the company's "Virtual Tumour" model predictions. The directors believe these results provide further validation as to the predictive capability of the

Read more
4 Mar 2011 11:08

Sareum soars after colon cancer study

Shares in Sareum were soaring after the cancer drug discovery business announced positive results from a study into colon cancer. The study, which was conducted by the Institute of Cancer Research, founded that Sareum's Chk1 inhibitor, used alongside a gemcitabine, a chemotherapeutic, "demonstrate

Read more
15 Feb 2011 16:44

London close: Late rally not enough

Weakness in the US sent shares into the red and a slight rally in late trading failed to lift the FTSE 100 into positive territory. US retail sales were up 0.3% in January, according to the Commerce Department, though they'd risen 0.5% the month before and were expected to do the same this time. Ex

Read more
16 Mar 2010 10:50

Small caps round-up: Amphion, Bioquell, Ablon...

Shares in Amphion Innovations jumped after the medical and technology sector said it was cautious but confident in the strength of its model following a year which saw revenue increase to $8.6m from $7.1m in 2008, but losses increase to $2.9m from $1.8m. Shares in Bioquell moved in the other direct

Read more
1 Mar 2010 11:04

Small caps round-up: Beowulf, E2V, Mobile Doctors...

Beowulf, owner of several exploration projects in Sweden, continues to believe in the commercial prospects for its asset portfolio which has increased in both quantity and quality as well as resource type. Losses grew to £520,000 in 2009 from £399,000 the year before, but it says future price tren

Read more
23 Jun 2009 09:04

Small caps round-up: Veris, Hightex, Inion ...

Property services group Veris posted a pre-tax loss of €6.7m versus the €4.8m profit last year due to the €11.3m write off of assts in the Moving and Storage division. Turnover grew by 29% in the year to €84.3m. "We anticipate that any new business wins in the short term will be offset to a greater

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.